397 related articles for article (PubMed ID: 27198856)
41. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
42. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug.
Mu Y; Fu Y; Li J; Yu X; Li Y; Wang Y; Wu X; Zhang K; Kong M; Feng C; Chen X
Carbohydr Polym; 2019 Jan; 203():10-18. PubMed ID: 30318192
[TBL] [Abstract][Full Text] [Related]
43. Fabrication of a Soybean Bowman-Birk Inhibitor (BBI) Nanodelivery Carrier To Improve Bioavailability of Curcumin.
Liu C; Cheng F; Yang X
J Agric Food Chem; 2017 Mar; 65(11):2426-2434. PubMed ID: 28249113
[TBL] [Abstract][Full Text] [Related]
44. Functionalization of nanodiamond with vitamin E TPGS to facilitate oral absorption of curcumin.
Cheng B; Pan H; Liu D; Li D; Li J; Yu S; Tan G; Pan W
Int J Pharm; 2018 Apr; 540(1-2):162-170. PubMed ID: 29452153
[TBL] [Abstract][Full Text] [Related]
45. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
46. [Pharmacokinetics and Intestinal Absorption of Curcumin Chitosan Hydrochloride Coated Liposome in Rats].
Wan SL; Zhong M; Yang M; Hu XY; Zhang JQ
Zhong Yao Cai; 2015 Jan; 38(1):132-5. PubMed ID: 26214883
[TBL] [Abstract][Full Text] [Related]
47. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
48. [Preparation of silymarin-loaded amphiphilic chitosan micelle and its in situ absorption in rat intestine].
Wu YP; Huo MR; Zhou JP
Yao Xue Xue Bao; 2009 Jun; 44(6):651-7. PubMed ID: 19806899
[TBL] [Abstract][Full Text] [Related]
49. Pluronic-Based Mixed Polymeric Micelles Enhance the Therapeutic Potential of Curcumin.
Akbar MU; Zia KM; Nazir A; Iqbal J; Ejaz SA; Akash MSH
AAPS PharmSciTech; 2018 Aug; 19(6):2719-2739. PubMed ID: 29978290
[TBL] [Abstract][Full Text] [Related]
50. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
51. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
52. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
53. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
54. In vivo evaluation of curcumin loaded nanosuspensions by oral administration.
Gao Y; Wang C; Sun M; Wang X; Yu A; Li A; Zhai G
J Biomed Nanotechnol; 2012 Aug; 8(4):659-68. PubMed ID: 22852475
[TBL] [Abstract][Full Text] [Related]
55. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
56. The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model.
Derakhshandeh K; Hosseinalizadeh A; Nikmohammadi M
Arch Pharm Res; 2011 Nov; 34(11):1989-97. PubMed ID: 22139699
[TBL] [Abstract][Full Text] [Related]
57. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.
Garg A; Bhalala K; Tomar DS; Wahajuddin
Int J Pharm; 2017 Jan; 516(1-2):120-130. PubMed ID: 27989820
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the intestinal permeability of ciclosporin using the in situ technique in rats and the relevance of P-glycoprotein.
Zakeri-Milani P; Valizadeh H; Islambulchilar Z; Damani S; Mehtari M
Arzneimittelforschung; 2008; 58(4):188-92. PubMed ID: 18540481
[TBL] [Abstract][Full Text] [Related]
59. Preparation and evaluation of curcumin-loaded self-assembled micelles.
Wang LL; He DD; Wang SX; Dai YH; Ju JM; Zhao CL
Drug Dev Ind Pharm; 2018 Apr; 44(4):563-569. PubMed ID: 29148846
[TBL] [Abstract][Full Text] [Related]
60. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
